CN103789420B - 一种α-地中海贫血荧光定量PCR检测试剂盒及其应用 - Google Patents
一种α-地中海贫血荧光定量PCR检测试剂盒及其应用 Download PDFInfo
- Publication number
- CN103789420B CN103789420B CN201410017893.0A CN201410017893A CN103789420B CN 103789420 B CN103789420 B CN 103789420B CN 201410017893 A CN201410017893 A CN 201410017893A CN 103789420 B CN103789420 B CN 103789420B
- Authority
- CN
- China
- Prior art keywords
- buffer solution
- thalassemia
- pcr
- probe
- primer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 201000006288 alpha thalassemia Diseases 0.000 title claims abstract description 71
- 238000001514 detection method Methods 0.000 title abstract description 24
- 238000003753 real-time PCR Methods 0.000 title abstract description 14
- 238000003752 polymerase chain reaction Methods 0.000 title abstract 4
- 239000000523 sample Substances 0.000 claims abstract description 100
- 102000004190 Enzymes Human genes 0.000 claims abstract description 31
- 108090000790 Enzymes Proteins 0.000 claims abstract description 31
- 239000007853 buffer solution Substances 0.000 claims description 59
- 230000003321 amplification Effects 0.000 claims description 37
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 37
- 238000001179 sorption measurement Methods 0.000 claims description 31
- 239000007788 liquid Substances 0.000 claims description 30
- 239000000376 reactant Substances 0.000 claims description 29
- 238000011144 upstream manufacturing Methods 0.000 claims description 26
- 239000000243 solution Substances 0.000 claims description 18
- UNXRWKVEANCORM-UHFFFAOYSA-N triphosphoric acid Chemical compound OP(O)(=O)OP(O)(=O)OP(O)(O)=O UNXRWKVEANCORM-UHFFFAOYSA-N 0.000 claims description 18
- 210000000349 chromosome Anatomy 0.000 claims description 13
- 102000040430 polynucleotide Human genes 0.000 claims description 13
- 108091033319 polynucleotide Proteins 0.000 claims description 13
- 239000002157 polynucleotide Substances 0.000 claims description 13
- 239000013642 negative control Substances 0.000 claims description 12
- 239000006166 lysate Substances 0.000 claims description 11
- 239000011535 reaction buffer Substances 0.000 claims description 11
- 239000005549 deoxyribonucleoside Substances 0.000 claims description 10
- 239000001226 triphosphate Substances 0.000 claims description 10
- 235000011178 triphosphate Nutrition 0.000 claims description 10
- 108090000623 proteins and genes Proteins 0.000 claims description 9
- MXHRCPNRJAMMIM-SHYZEUOFSA-N 2'-deoxyuridine Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C=C1 MXHRCPNRJAMMIM-SHYZEUOFSA-N 0.000 claims description 8
- UDGUGZTYGWUUSG-UHFFFAOYSA-N 4-[4-[[2,5-dimethoxy-4-[(4-nitrophenyl)diazenyl]phenyl]diazenyl]-n-methylanilino]butanoic acid Chemical compound COC=1C=C(N=NC=2C=CC(=CC=2)N(C)CCCC(O)=O)C(OC)=CC=1N=NC1=CC=C([N+]([O-])=O)C=C1 UDGUGZTYGWUUSG-UHFFFAOYSA-N 0.000 claims description 8
- WCKQPPQRFNHPRJ-UHFFFAOYSA-N 4-[[4-(dimethylamino)phenyl]diazenyl]benzoic acid Chemical compound C1=CC(N(C)C)=CC=C1N=NC1=CC=C(C(O)=O)C=C1 WCKQPPQRFNHPRJ-UHFFFAOYSA-N 0.000 claims description 8
- 108010067770 Endopeptidase K Proteins 0.000 claims description 8
- MXHRCPNRJAMMIM-UHFFFAOYSA-N desoxyuridine Natural products C1C(O)C(CO)OC1N1C(=O)NC(=O)C=C1 MXHRCPNRJAMMIM-UHFFFAOYSA-N 0.000 claims description 8
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 8
- ABZLKHKQJHEPAX-UHFFFAOYSA-N tetramethylrhodamine Chemical compound C=12C=CC(N(C)C)=CC2=[O+]C2=CC(N(C)C)=CC=C2C=1C1=CC=CC=C1C([O-])=O ABZLKHKQJHEPAX-UHFFFAOYSA-N 0.000 claims description 8
- 229940048102 triphosphoric acid Drugs 0.000 claims description 8
- 101150028074 2 gene Proteins 0.000 claims description 7
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 claims description 4
- 238000012217 deletion Methods 0.000 abstract description 24
- 230000037430 deletion Effects 0.000 abstract description 24
- 210000005259 peripheral blood Anatomy 0.000 abstract description 14
- 239000011886 peripheral blood Substances 0.000 abstract description 14
- 238000013399 early diagnosis Methods 0.000 abstract description 5
- 230000035945 sensitivity Effects 0.000 abstract description 5
- 238000000034 method Methods 0.000 description 25
- 239000000975 dye Substances 0.000 description 19
- 102000039446 nucleic acids Human genes 0.000 description 18
- 108020004707 nucleic acids Proteins 0.000 description 18
- 150000007523 nucleic acids Chemical class 0.000 description 18
- 238000006243 chemical reaction Methods 0.000 description 15
- 238000002474 experimental method Methods 0.000 description 15
- 238000002156 mixing Methods 0.000 description 13
- 102100037111 Uracil-DNA glycosylase Human genes 0.000 description 12
- 230000008034 disappearance Effects 0.000 description 10
- 239000002699 waste material Substances 0.000 description 10
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 8
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 8
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 8
- 230000000694 effects Effects 0.000 description 8
- 238000000605 extraction Methods 0.000 description 8
- 238000010606 normalization Methods 0.000 description 7
- 238000001556 precipitation Methods 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 6
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- 230000015572 biosynthetic process Effects 0.000 description 6
- 238000003786 synthesis reaction Methods 0.000 description 6
- 239000000047 product Substances 0.000 description 5
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 238000009835 boiling Methods 0.000 description 4
- 238000005336 cracking Methods 0.000 description 4
- 238000001917 fluorescence detection Methods 0.000 description 4
- 229910001629 magnesium chloride Inorganic materials 0.000 description 4
- 210000004940 nucleus Anatomy 0.000 description 4
- 239000001103 potassium chloride Substances 0.000 description 4
- 235000011164 potassium chloride Nutrition 0.000 description 4
- 230000002265 prevention Effects 0.000 description 4
- 238000000197 pyrolysis Methods 0.000 description 4
- 238000003908 quality control method Methods 0.000 description 4
- 239000006228 supernatant Substances 0.000 description 4
- 102000006943 Uracil-DNA Glycosidase Human genes 0.000 description 3
- 108010072685 Uracil-DNA Glycosidase Proteins 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 238000005119 centrifugation Methods 0.000 description 3
- SUYVUBYJARFZHO-RRKCRQDMSA-N dATP Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-RRKCRQDMSA-N 0.000 description 3
- SUYVUBYJARFZHO-UHFFFAOYSA-N dATP Natural products C1=NC=2C(N)=NC=NC=2N1C1CC(O)C(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-UHFFFAOYSA-N 0.000 description 3
- RGWHQCVHVJXOKC-SHYZEUOFSA-J dCTP(4-) Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)C1 RGWHQCVHVJXOKC-SHYZEUOFSA-J 0.000 description 3
- HAAZLUGHYHWQIW-KVQBGUIXSA-N dGTP Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 HAAZLUGHYHWQIW-KVQBGUIXSA-N 0.000 description 3
- NHVNXKFIZYSCEB-XLPZGREQSA-N dTTP Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C1 NHVNXKFIZYSCEB-XLPZGREQSA-N 0.000 description 3
- 230000009849 deactivation Effects 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 239000012535 impurity Substances 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 230000001351 cycling effect Effects 0.000 description 2
- 239000012149 elution buffer Substances 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 238000000703 high-speed centrifugation Methods 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000012797 qualification Methods 0.000 description 2
- 208000026350 Inborn Genetic disease Diseases 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 208000002903 Thalassemia Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000003416 augmentation Effects 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 231100000357 carcinogen Toxicity 0.000 description 1
- 239000003183 carcinogenic agent Substances 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- 208000016361 genetic disease Diseases 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 208000007475 hemolytic anemia Diseases 0.000 description 1
- 231100000518 lethal Toxicity 0.000 description 1
- 230000001665 lethal effect Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/686—Polymerase chain reaction [PCR]
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
Claims (12)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410017893.0A CN103789420B (zh) | 2014-01-15 | 2014-01-15 | 一种α-地中海贫血荧光定量PCR检测试剂盒及其应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410017893.0A CN103789420B (zh) | 2014-01-15 | 2014-01-15 | 一种α-地中海贫血荧光定量PCR检测试剂盒及其应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103789420A CN103789420A (zh) | 2014-05-14 |
CN103789420B true CN103789420B (zh) | 2015-03-25 |
Family
ID=50665472
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410017893.0A Active CN103789420B (zh) | 2014-01-15 | 2014-01-15 | 一种α-地中海贫血荧光定量PCR检测试剂盒及其应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103789420B (zh) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109112205A (zh) * | 2017-06-23 | 2019-01-01 | 陈治中 | 用于基因分型检测3种缺失型α地中海贫血的引物组及试剂盒 |
CN109112203A (zh) * | 2017-06-23 | 2019-01-01 | 陈治中 | 用于基因分型检测α+缺失型地中海贫血的引物组及试剂盒 |
CN109112208A (zh) * | 2017-06-23 | 2019-01-01 | 陈治中 | 用于检测缺失型α-地中海贫血的引物组及试剂盒 |
CN107287324A (zh) * | 2017-07-20 | 2017-10-24 | 成都海之元生物科技有限公司 | 检测基因片段缺失的试剂盒及其检测方法 |
CN111471763B (zh) * | 2020-06-17 | 2023-06-02 | 厦门安普利生物工程有限公司 | 用于α-地中海贫血多重实时荧光PCR检测的引物、探针和反应缓冲液组合及试剂盒 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1626671A (zh) * | 2003-12-10 | 2005-06-15 | 深圳益生堂生物企业有限公司 | 缺失型α珠蛋白基因的多重PCR检测 |
CN1661098A (zh) * | 2004-12-29 | 2005-08-31 | 深圳益生堂生物企业有限公司 | 缺失型α-地中海贫血基因诊断芯片 |
-
2014
- 2014-01-15 CN CN201410017893.0A patent/CN103789420B/zh active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1626671A (zh) * | 2003-12-10 | 2005-06-15 | 深圳益生堂生物企业有限公司 | 缺失型α珠蛋白基因的多重PCR检测 |
CN1661098A (zh) * | 2004-12-29 | 2005-08-31 | 深圳益生堂生物企业有限公司 | 缺失型α-地中海贫血基因诊断芯片 |
Non-Patent Citations (1)
Title |
---|
多重荧光定量PCR快速检测缺失型α地中海贫血;彭建明等;《广东医学》;20130430;第34卷(第8期);1195-1196 * |
Also Published As
Publication number | Publication date |
---|---|
CN103789420A (zh) | 2014-05-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102174660B (zh) | 乙型肝炎病毒荧光定量pcr检测试剂盒 | |
CN103789420B (zh) | 一种α-地中海贫血荧光定量PCR检测试剂盒及其应用 | |
CN101701267B (zh) | 乙型肝炎病毒荧光定量pcr检测试剂盒及其应用 | |
CN103060451B (zh) | 一种肺炎支原体mp检测试剂盒 | |
CN103740832B (zh) | 一种新型隐球菌检测试剂盒 | |
CN102876776B (zh) | 检测y染色体微缺失的实时荧光定量pcr试剂盒及方法 | |
CN101376912B (zh) | 甲3型流感病毒的环介导等温扩增检测试剂盒及检测方法 | |
CN103725798A (zh) | 用于以rt-lamp法检测肾综合征出血热病毒的引物、试剂盒、检测方法 | |
CN103725800B (zh) | 一种人腺病毒检测试剂盒 | |
CN102925558B (zh) | 一种检测PML-RARa融合基因mRNA表达量的试剂盒 | |
CN103074428B (zh) | 一种结核分枝杆菌tb检测试剂盒 | |
CN102634572A (zh) | 一种荧光定量RT-PCR检测融合基因E2A-PBX1 mRNA表达的试剂盒 | |
CN103074429B (zh) | 解脲脲原体uu检测试剂盒 | |
CN105176995A (zh) | 基于水解探针法的可同时检测地中海贫血-α21.9缺失型和α2变异的试剂盒 | |
CN105821145A (zh) | 一种用于检测HLA-DQ基因rs9275319位点多态性的引物及检测方法 | |
CN102146467A (zh) | 检测鼠疫耶尔森氏菌的试剂及荧光定量pcr检测鼠疫耶尔森氏菌的方法 | |
CN102533967B (zh) | 霍乱弧菌毒素基因多重实时荧光定量pcr检测试剂盒及方法 | |
CN104762379A (zh) | 一种疟原虫检测试剂盒 | |
CN103757111B (zh) | 一种α-地中海贫血荧光定量PCR检测试剂盒及其应用 | |
CN103740834A (zh) | 一种白色念珠菌检测试剂盒 | |
CN102181584B (zh) | 一种基于基因测序法的乙型肝炎病毒基因分型试剂盒 | |
CN101974621B (zh) | 一种牛巴贝斯虫lamp检测方法 | |
CN105734172B (zh) | 一种快速检测猪瘟病毒/猪繁殖与呼吸综合征病毒/猪伪狂犬病毒/猪细小病毒的试剂盒 | |
CN103710466B (zh) | 一种hbv的ymdd荧光pcr检测试剂盒 | |
CN104561317A (zh) | 一种梅毒螺旋体荧光pcr检测试剂盒 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: HUNAN SHENGXIANG BIOLOGICAL TECHNOLOGY CO., LTD. Free format text: FORMER OWNER: HUNAN SHENGWEIER MEDICAL INSPECTION CO., LTD. Effective date: 20150602 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20150602 Address after: 410012, No. 680, Lu Song Road, hi tech Development Zone, Hunan, Changsha Patentee after: Sansure Biotech Inc. Address before: 410012 No. 680, Lu Song Road, hi tech Industrial Development Zone, Hunan, Changsha Patentee before: Hunan company limited of Sheng Weier medical test institute |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Fluorescence quantitative polymerase chain reaction (PCR) detection kit for alpha-thalassemia and application thereof Effective date of registration: 20170711 Granted publication date: 20150325 Pledgee: Ningbo free trade zone Terry with equity investment partnership (limited partnership)|Suzhou equity equity investment center (limited partnership)|Ningbo Meishan Bonded Port District, Jun and equity investment partnership (limited partnership)|Chen Bang Pledgor: Hunan Gene Technology Co.|Hunan San Xiang Biological Technology Co. Ltd. Registration number: 2017430000042 |
|
CP03 | Change of name, title or address | ||
CP03 | Change of name, title or address |
Address after: 410205 Changsha province high and New Technology Industrial Development Zone, Lu Pine Road, No. 680, Hunan Patentee after: Shengxiang Biotechnology Co., Ltd Address before: 410012, No. 680, Lu Song Road, hi tech Development Zone, Hunan, Changsha Patentee before: Sansure Biotech Inc. |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20200217 Granted publication date: 20150325 Pledgee: Suzhou Lirui equity investment center (limited partnership)|Triton equity investment partnership (limited partnership)|JUNHE Tongrui equity investment partnership (limited partnership)|Chenbang Pledgor: SANSURE BIOTECH Inc. Registration number: 2017430000042 |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20210315 Address after: 201108 2nd floor, building 2, no.479 Chundong road and No.128 Shenfu Road, Minhang District, Shanghai Patentee after: Shengxiang (Shanghai) Gene Technology Co.,Ltd. Address before: No. 680, lushong Road, high tech Industrial Development Zone, Changsha City, Hunan Province, 410205 Patentee before: Shengxiang Biotechnology Co.,Ltd. |